Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery

ClinicalTrials.gov ID: NCT00161733

Public ClinicalTrials.gov record NCT00161733. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 3:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to demonstrate equivalent hemostatic efficacy and safety between FS VH S/D and TISSEEL VH fibrin sealant in subjects undergoing cardiac surgery requiring cardiopulmonary bypass. If bleeding is still present after conventional surgical methods to achieve hemostasis have been applied FS VH S/D or Tisseel VH are applied. Achievement of hemostasis within 5 minutes is compared between the study groups.

Study identification

NCT ID
NCT00161733
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Baxter Healthcare Corporation
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2002 (Type not available)
Primary completion
Not listed
Completion
Nov 2004 (Type not available)
Last update posted
Apr 5, 2017

2002 – 2004

United States locations

U.S. sites
22
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
Banner Health Research Institute Phoenix Arizona 85006 —
UCI Medical Center Orange California 92868-3298 —
Shands Hospital at the University of Florida Gainesville Florida 32610-0286 —
Brevard Cardio Surgeons/Health First Heart Institute Melbourne Florida 32901 —
Peachtree Cardiovascular Atlanta Georgia 30342 —
St. Joseph's/Candler Health System, Inc. Savannah Georgia 31405 —
University of Chicago Medical Center Chicago Illinois 60637 —
University of Kentucky Medical Center Lexington Kentucky 40536-0293 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215-5501 —
Cardiac Surgery Service, Baystate Medical Center Springfield Massachusetts 01199 —
University of Michigan Hospital Ann Arbor Michigan 48109-0344 —
Washington University Medical Center St Louis Missouri 63110 —
UMDNJ - Robert Wood Johnson Medical School Camden New Jersey 08103 —
Lenox Hill Hospital New York New York 10021 —
Duke University Medical Center Durham North Carolina 27710 —
The Linder Clinical Trial Center Cincinnati Ohio 45219 —
The Cleveland Clinic Cleveland Ohio 44195 —
The Oregon Clinic Portland Oregon 97213 —
Baylor University Medical Center Dallas Texas 75246 —
University of Virginia Health System Charlottesville Virginia 22908 —
Sentara Norfolk General Hospital Norfolk Virginia 23507 —
Franciscan Health System Research Center Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00161733, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 5, 2017 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00161733 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →